G1 Therapeutics Inc

JPMORGAN CHASE & CO

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/12/2024

Shares

21,029

Value ($000)

48

Weight

0.0%

2019 Q4 - 2024 Q2 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/12/2024	48	0.0%	21,029	6/30/2024
2024 Q1	5/10/2024	236	0.0%	54,634	3/31/2024
2023 Q4	2/12/2024	1	0.0%	250	12/31/2023
2023 Q3	11/14/2023	13	0.0%	9,360	9/30/2023
2023 Q2	8/11/2023	5,269	0.0%	2,115,873	6/30/2023
2023 Q1	5/18/2023	5,761	0.0%	2,149,526	3/31/2023
2022 Q4	2/13/2023	11,053	0.0%	2,035,622	12/31/2022
2022 Q3	11/14/2022	25,527	0.0%	2,043,773	9/30/2022
2022 Q2	8/11/2022	10,520	0.0%	2,129,449	6/30/2022
2022 Q1	5/11/2022	15,943	0.0%	2,097,753	3/31/2022
2021 Q4	2/11/2022	21,887	0.0%	2,143,684	12/31/2021
2021 Q3	11/12/2021	30,058	0.0%	2,239,679	9/30/2021
2021 Q2	8/12/2021	41,162	0.0%	1,876,160	6/30/2021
2021 Q1	5/12/2021	43,980	0.0%	1,827,889	3/31/2021
2020 Q4	2/19/2021	30,015	0.0%	1,668,422	12/31/2020
2020 Q3	11/12/2020	19,837	0.0%	1,664,181	9/30/2020
2020 Q2	8/11/2020	49,628	0.0%	2,045,708	6/30/2020
2020 Q1	5/12/2020	18,689	0.0%	1,695,819	3/31/2020
2019 Q4	2/11/2020	44,115	0.0%	1,669,139	12/31/2019